Colangelo Dominick 4
4 · Vericel Corp · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Vericel (VCEL) CEO Dominick Colangelo Exercises RSUs; 8,824 Withheld
What Happened
- Dominick Colangelo, President, CEO and a director of Vericel (VCEL), had restricted stock units (RSUs) vest on Feb 24, 2026 and those vested units were converted into deferred phantom stock units under Vericel’s Deferred Compensation Plan. The filing shows 18,250 shares recorded as acquired via conversion/exercise of derivative securities (code M).
- To cover tax withholding related to the vesting, 8,824 shares were withheld (code F) at a fair market value of $38.09 per share, resulting in proceeds/value of $336,106. This withholding is a disposition of shares to satisfy tax obligations, not an open‑market sale.
Key Details
- Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (filed within the typical two-business-day window).
- Acquired: 18,250 shares reported as converted/exercised derivatives (RSUs → phantom stock units); Disposed (withheld for taxes): 8,824 shares at $38.09 each, total ~$336,106.
- Footnotes: vested RSUs converted into phantom stock units and are deferred under the Vericel Deferred Compensation Plan (will be payable in shares on the elected distribution date). Each RSU equals one share; some RSUs originated from prior grants (Feb 22, 2024 and Feb 20, 2025). Withholding was used to satisfy tax withholding requirements.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Transaction codes: M = exercise/conversion of derivative security (RSU conversion); F = payment of exercise price or tax liability (share withholding).
Context
- This was not an open-market purchase or sale by Colangelo that signals a fresh buy/sell decision; it reflects routine vesting of RSUs and standard tax-withholding. The converted units were deferred as phantom shares, meaning payout in actual shares will occur later per the deferred compensation election.
Insider Transaction Report
Form 4
Vericel CorpVCEL
Colangelo Dominick
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
[F1][F2][F3]2026-02-24+18,250→ 303,020 total - Exercise/Conversion
Common Stock
[F4][F3]2026-02-24+18,250→ 321,270 total - Tax Payment
Common Stock
[F5][F3]2026-02-24$38.09/sh−8,824$336,106→ 312,446 total - Exercise/Conversion
Restricted Stock Unit
[F6][F2][F7]2026-02-24+18,250→ 36,500 total→ Common Stock (18,250 underlying) - Exercise/Conversion
Restricted Stock Unit
[F6][F8][F4][F7]2026-02-24+18,250→ 54,750 total→ Common Stock (18,250 underlying)
Footnotes (8)
- [F1]The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date.
- [F2]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 18,250 shares of Common Stock and instead received 18,250 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan.
- [F3]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F4]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
- [F5]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
- [F6]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F7]No expiration date for this type of award.
- [F8]The Fair Market Value of the vested derivative securities is $38.09 per share.
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Dominick C. Colangelo|2026-02-26